These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 4976352)

  • 101. Prevention of recurrent superficial bladder cancer.
    Aso Y
    Curr Urol Rep; 2002 Oct; 3(5):335-6. PubMed ID: 12354339
    [No Abstract]   [Full Text] [Related]  

  • 102. Case-cohort analysis of clusters of recurrent events.
    Chen F; Chen K
    Lifetime Data Anal; 2014 Jan; 20(1):1-15. PubMed ID: 23832308
    [TBL] [Abstract][Full Text] [Related]  

  • 103. Depigmentation of eyelids after topically administered thiotepa.
    Berkow JW; Gills JP; Wise JB
    Arch Ophthalmol; 1969 Sep; 82(3):415-20. PubMed ID: 4979838
    [No Abstract]   [Full Text] [Related]  

  • 104. A method to compare two samples of recurrence data.
    Doganaksoy N; Nelson W
    Lifetime Data Anal; 1998; 4(1):51-63. PubMed ID: 9567055
    [TBL] [Abstract][Full Text] [Related]  

  • 105. Recurrence of bladder tumors by surgical implantation.
    HINMAN F
    J Urol; 1956 Apr; 75(4):695-6. PubMed ID: 13307773
    [No Abstract]   [Full Text] [Related]  

  • 106. [Diagnosis, therapy and prophylaxis of bladder tumors].
    PIERACCINI P
    Sperimentale; 1948; 99(1-6):259. PubMed ID: 18099429
    [No Abstract]   [Full Text] [Related]  

  • 107. Thiotepa versus Bacille Calmette-Guérin in Non-Muscle Invasive Bladder Cancer.
    Fallah F; Fallah M; Sajadi Nia RS
    Curr Urol; 2013 Jan; 6(3):160-4. PubMed ID: 24917736
    [TBL] [Abstract][Full Text] [Related]  

  • 108. Genitourinary malignancies.
    Connolly JG
    Can Fam Physician; 1975 Dec; 21(12):38-43. PubMed ID: 20469262
    [TBL] [Abstract][Full Text] [Related]  

  • 109. Early onset life-threatening myelosuppression after low dose of intravesical thiotepa.
    Agnelli G; de Cunto M; Gresele P; del Favero A
    Postgrad Med J; 1982 Jun; 58(680):380-1. PubMed ID: 6812036
    [TBL] [Abstract][Full Text] [Related]  

  • 110. Treatment of superficial bladder cancer.
    Morales A
    Can Med Assoc J; 1980 May; 122(10):1133-8. PubMed ID: 6770987
    [TBL] [Abstract][Full Text] [Related]  

  • 111. Intravesical adriamycin chemotherapy in bladder cancer.
    Matsumura Y; Ozaki Y; Ohmori H
    Cancer Chemother Pharmacol; 1983; 11 Suppl():S69-73. PubMed ID: 6640838
    [TBL] [Abstract][Full Text] [Related]  

  • 112. Cooperative studies of chemoprophylaxis after transurethral resection of bladder tumors.
    Pavone-Macaluso M; Tripi M; Ingargiola GB
    Cancer Chemother Pharmacol; 1983; 11 Suppl():S16-21. PubMed ID: 6416698
    [TBL] [Abstract][Full Text] [Related]  

  • 113. Intravesical chemotherapy in the United States. An overview.
    Spaulding JT
    Cancer Chemother Pharmacol; 1983; 11 Suppl():S5-8. PubMed ID: 6196136
    [TBL] [Abstract][Full Text] [Related]  

  • 114. Effects of hyperthermia on bladder cancer.
    Hall RR; Schade RO; Swinney J
    Br Med J; 1974 Jun; 2(5919):593-4. PubMed ID: 4833966
    [TBL] [Abstract][Full Text] [Related]  

  • 115. Bladder hyperthermia in the treatment of vesical papillomatosis.
    Lunglmayr G; Czech K; Zekert F; Kellner G
    Int Urol Nephrol; 1973 Jan; 5(1):75-84. PubMed ID: 4203803
    [No Abstract]   [Full Text] [Related]  

  • 116. Intravesical chemotherapy.
    Obama T; Matsumura Y; Ohmori H
    Cancer Chemother Pharmacol; 1987; 20 Suppl():S60-2. PubMed ID: 3664946
    [TBL] [Abstract][Full Text] [Related]  

  • 117. Prophylactic treatment for superficial bladder cancer following transurethral resection.
    Hirao Y; Okajima E; Ohara S; Ozono S; Hiramatsu T; Yoshida K; Yamada K; Aoyama H; Hashimoto M; Watanabe S
    Cancer Chemother Pharmacol; 1987; 20 Suppl():S85-90. PubMed ID: 3117402
    [TBL] [Abstract][Full Text] [Related]  

  • 118. Histopathology of BCG and thiotepa treated bladders.
    Guinan P; Shaw M; Ray V
    Urol Res; 1986; 14(4):211-5. PubMed ID: 3097901
    [TBL] [Abstract][Full Text] [Related]  

  • 119. Verapamil enhanced in vitro chemosensitivity of a murine bladder carcinoma, FCB.
    Ballou RJ; Simpson WG; Harty JI; Tseng MT
    Urol Res; 1986; 14(4):195-200. PubMed ID: 3097900
    [TBL] [Abstract][Full Text] [Related]  

  • 120. On the search for new anticancer drugs 14: the plasma pharmacokinetics and tissue distribution of spin-labeled thio-TEPA (SL-O-TT).
    Gutierrez PL; Cohen BE; Sosnovsky G; Davis TA; Egorin MJ
    Cancer Chemother Pharmacol; 1985; 15(3):185-91. PubMed ID: 2996798
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.